Opendata, web and dolomites

HUMANeye SIGNED

Implantable titanium net to combat pathological corneal shape deformations

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 HUMANeye project word cloud

Explore the words cloud of the HUMANeye project. It provides you a very rough idea of what is the project "HUMANeye" about.

disability    commercial    titanium    2027    medical    2023    deep    tend    centres    reducing    layers    uniquely    unpredictable    deformations    manufacture    withstand    launch    halts    employment    correction    humaneye    sme    pcsd    aggressive    chain    9m    limited    cornea    error    spiraling    transplantation    global    progression    considerably    rates    hi    save    cumulative    pathological    net    profits    shape    errors    reproducible    tissue    matches    ophthalmic    shaped    direct    adults    public    disease    quality    66    revenues    10    48    multiple    fashioned    compromised    grade    reductive    architecture    generate    life    ring    indirect    gives    stronger    jobs    patients    predicted    breakthrough    corrects    surgery    corneal    smes    successfully    54    visual    70    until    tech    internal    295k    license    worth    21    treatment    2019    laser    market    necessitating    natural    push    world    operations    implanted    options    dome    productivity    care    entire    2050    potently    1bn    14k    implantation    severely    population    rollout    prove    severe    103    healthcare    clinic    938k    young    external    implants    refractive    unites    trillion    6m    patient   

Project "HUMANeye" data sheet

The following table provides information about the project.

Coordinator
FUNDACIO DE RECERCA DEL INSTITUT DE MICROCIRURGIA OCULAR 

Organization address
address: CARRER JOSEP MARIA LLADO, 3
city: Barcelona
postcode: 8024
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Total cost 1˙997˙847 €
 EC max contribution 1˙632˙797 € (82%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-EIC-FTI-2018-2020
 Funding Scheme IA
 Starting year 2019
 Duration (year-month-day) from 2019-11-01   to  2022-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    FUNDACIO DE RECERCA DEL INSTITUT DE MICROCIRURGIA OCULAR ES (Barcelona) coordinator 541˙037.00
2    RECORNEA SRL IT (MARTIGNACCO UD) participant 553˙401.00
3    BLUEACRE TECHNOLOGY LIMITED IE (DUNDALK) participant 298˙379.00
4    CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE FR (TOULOUSE CEDEX 3) participant 239˙980.00

Map

 Project objective

The global costs from visual refractive errors will reach some €1.2 trillion in 2019. This type of disability is on the increase and it is predicted that it will affect 10% of the World population by 2050. Pathological corneal shape deformations (PCSD) are a common cause of severe refractive error that tend to occur in young adults, considerably reducing both their quality of life and work productivity. Current treatment options are severely limited. The compromised cornea cannot withstand aggressive reductive laser surgery. Corneal transplantation gives highly unpredictable results, necessitating multiple operations that lead to spiraling treatment costs of over €14k per patient.

HUMANEYE is a breakthrough dome-shaped corneal net fashioned in medical-grade titanium. Implanted deep within the cornea, it potently corrects refractive error and halts disease progression in PCSD. It uniquely matches the natural architecture of tissue layers throughout the entire tissue, leading to simple reproducible implantation, 70% higher success rates and 66% stronger refractive correction than current ring-shaped implants on the market today.

The HUMANeye project unites two hi-tech SMEs, to manufacture the technology and push it to market, with two leading European ophthalmic care centres to prove its worth in the clinic. From HUMANEYE launch in 2023 until 2027, our SME partners will together generate €103.6m in cumulative revenues and €54.9m in profits. Rollout with an established commercial license partner will generate 21 internal and 48 external jobs in our value chain. 938k successfully operations will help 295k patients to better employment and save €20.1bn in direct public healthcare and indirect productivity costs.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "HUMANEYE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "HUMANEYE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.1.)

GoSafe (2019)

Restoring complete sensory ability for natural walking of amputees

Read More  

BIOSNAP (2019)

SMART, SUSTAINABLE & CONVENIENT UNIT DOSE PACKAGING

Read More  

GIoT (2019)

Nano-satellites based Global Infrastructure to Enable IoT/M2M Networks - GIoT (Global IoT)

Read More